-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Merck & Co., Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
- Merck & Co., Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $426M.
- Merck & Co., Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $2.8B, a 85.4% increase year-over-year.
- Merck & Co., Inc. annual Income Tax Expense (Benefit) for 2024 was $2.8B, a 85.4% increase from 2023.
- Merck & Co., Inc. annual Income Tax Expense (Benefit) for 2023 was $1.51B, a 21.2% decline from 2022.
- Merck & Co., Inc. annual Income Tax Expense (Benefit) for 2022 was $1.92B, a 26.1% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)